American Gastroenterological Association Institute Guideline on the pharmacological management of irritable bowel syndrome.
about
Diagnosis and management of functional symptoms in inflammatory bowel disease in remissionTHE INTESTINAL MICROBIOTA AND THE ROLE OF PROBIOTICS IN IRRITABLE BOWEL SYNDROME: a reviewA meta-analysis and systematic review of the comorbidity between irritable bowel syndrome and bipolar disorderRifaximin and eluxadoline - newly approved treatments for diarrhea-predominant irritable bowel syndrome: what is their role in clinical practice alongside alosetron?Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic DichotomyColonic dysmotility and morphological abnormality frequently detected in Japanese patients with irritable bowel syndrome.Relationship between use of selective serotonin reuptake inhibitors and irritable bowel syndrome: A population-based cohort studyNew and Emerging Treatment Options for Irritable Bowel Syndrome.Advances in IBS 2016: A Review of Current and Emerging Data.Treatment Algorithm for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Derived from a Canadian National Survey and Needs Assessment on Choices of Therapeutic AgentsTherapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology.How to Diagnose and Treat IBD Mimics in the Refractory IBD Patient Who Does Not Have IBD.From clinical uncertainties to precision medicine: the emerging role of the gut barrier and microbiome in small bowel functional diseases.Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPsEluxadoline (Viberzi): A Mu-Opioid Receptor Agonist for the Treatment Of Irritable Bowel Syndrome With Diarrhea.The place of eluxadoline in the management of irritable bowel syndrome with diarrhea.Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome.Diagnosis and treatment of irritable bowel syndrome with predominant constipation in the primary-care setting: focus on linaclotide.Irritable Bowel Syndrome.Clinical Practice Guidelines for Irritable Bowel Syndrome in Korea, 2017 Revised Edition.Short-course therapy for diarrhea-predominant irritable bowel syndrome: understanding the mechanism, impact on gut microbiota, and safety and tolerability of rifaximin
P2860
Q26768264-66783438-EC4A-482C-A963-7E9D2B5E618EQ26769725-C8F11040-17C3-4241-AC15-3F2E366F2AFCQ30248419-C1207FB1-591C-4736-B5E5-BDA53FD044C7Q33466527-BE14D8F0-2B34-4986-9F9B-98943BDDB0D2Q33469991-F5EF3B63-CADD-4980-84BF-12E6242CC2D1Q33679174-8A2B3FE9-BD41-4C55-81B9-395F61E74D83Q33719985-CD57EEB6-576B-4979-AFD8-F70496C41210Q36180769-DBF79CBE-2DA3-4498-BA4F-E6E4D70BCCB3Q36245061-8552C274-B524-4A1A-AA8E-B8A986703A9DQ37657368-92997EF9-E4DE-4466-B72A-8ED0AA5F2528Q38445280-6EDB85F6-F17A-4E9B-A603-624A4A16AE76Q38739354-E09FB533-F882-4533-851C-F3D15B7DD513Q39376100-3B0A22CA-FDD7-47E9-89F3-AF7DB9C2DDC3Q40976092-D9B52304-B1EB-4106-86DB-6964697E3F19Q41064891-D72E0007-6740-4E81-A09E-C0C0595D5324Q41078536-9BD68C54-32F9-4B8C-9079-AE91CAE8BF98Q42370590-51665867-4339-43B8-902B-7EC7820004C3Q45842056-C1C96766-C731-44BC-8F27-890259DE2D65Q50861627-A7D39F18-079A-4B14-8BB7-18A68FF0E734Q55312184-BBEBB947-1D69-4A03-A0FA-F1C8F0DFFBFDQ57070200-6E25A077-7CFD-436E-A0EC-EB9F704C2BD3
P2860
American Gastroenterological Association Institute Guideline on the pharmacological management of irritable bowel syndrome.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
American Gastroenterological A ...... t of irritable bowel syndrome.
@en
American Gastroenterological A ...... t of irritable bowel syndrome.
@nl
type
label
American Gastroenterological A ...... t of irritable bowel syndrome.
@en
American Gastroenterological A ...... t of irritable bowel syndrome.
@nl
prefLabel
American Gastroenterological A ...... t of irritable bowel syndrome.
@en
American Gastroenterological A ...... t of irritable bowel syndrome.
@nl
P2093
P1433
P1476
American Gastroenterological A ...... t of irritable bowel syndrome.
@en
P2093
Amercian Gastroenterological Association
David S Weinberg
Joel J Heidelbaugh
Walter Smalley
P304
P356
10.1053/J.GASTRO.2014.09.001
P407
P577
2014-09-16T00:00:00Z